BUHLMANN Citations Archives - Page 5 of 14 - Buhlmann Diagnostics Corp

Category: BUHLMANN Citations

A number of the publications in the citation list describe applications that are outside of product claims thus they should be used for information only.

The New Biosimilar of Infliximab SB2 Can be Quantified by IFX-Optimized Therapeutic Drug Monitoring Assays

BÜHLMANN Quantum Blue® Infliximab Citation: Magro, F., Rocha, C. et al. P229 The new biosimilar of infliximab SB2 can be quantified by IFX-optimized therapeutic drug monitoring assays.  Journal of Crohns and Colitis.  2018, Jan. DOI: 10.1093/ecco-jcc/jjx180.356. BÜHLMANN Quantum Blue® Infliximab is for Research Use Only in the US.  Not for use in diagnostic procedures in the US. Health Canada License:
Continue Reading

A Pilot Study Using Point of Care Testing for Infliximab and Faecal Calprotectin in IBD Patients

BÜHLMANN Quantum Blue® Infliximab Citation: Sophie Restellini, Talat Bessissow, Carolyne Lemieux, Che-Yung Chao, Gary Wild, Ernest Seidman, Alain Bitton, Peter L. Lakatos, Waqqas Afif.  P711 A pilot study using point of care testing for infliximab and faecal calprotectin in IBD patients with a secondary loss of response.  Journal of Crohn's and Colitis. 2018 Jan. DOI: 10.1093/ecco-jcc/jjx180.838. Highlight from this
Continue Reading

The Clinical Utility of Basophil Activation Testing in Diagnosis and Monitoring of Allergic Disease

Chronic Urticaria and BAT Guidelines: Hoffmann HJ, Santos AF, Mayorga C, Nopp A, Eberlein B, Ferrer M, Rouzaire P, Ebo DG, Sabato V, Sanz ML, Pecaric-Petkovic T, Patil SU, Hausmann OV, Shreffler WG, Korosec P, Knol EF. The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease. Allergy. 2015 Nov;70(11):1393-405. Epub
Continue Reading

The EAACI/GA(2) LEN/EDF/WAO Guideline for the Definition, Classification, Diagnosis, and Management of Urticaria

Chronic Urticaria and BAT Guidelines: Zuberbier T, et al;; European Academy of Allergy and Clinical Immunology; Global Allergy and Asthma European Network; European Dermatology Forum; World Allergy Organization. The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy. 2014 Jul;69(7):868-87.  Epub 2014 Apr 30. PubMed PMID:
Continue Reading

Functional and Phenotypic Analysis of Basophils Allows Determining Distinct Subtypes in Patients with Chronic urticaria

Flow CAST® Assay: Rauber MM, Pickert J, Holiangu L, Möbs C, Pfützner W. Functional and phenotypic analysis of basophils allows determining distinct subtypes in patients with chronic urticaria. Allergy. 2017 Dec;72(12):1904-1911. . Epub 2017 Jul 12. PubMed PMID: 28585360; doi:10.1111/all.13215 Highlights from this Publication “CU can be categorized into three immunologic subgroups based on their basophil
Continue Reading

Positive CD63 Basophil Activation Tests Are Common in Children with Chronic Spontaneous Urticaria and Linked to High Disease Activity

Flow CAST® Assay:   Netchiporouk E, Moreau L, Rahme E, Maurer M, Lejtenyi D, Ben-Shoshan M. Positive CD63 Basophil Activation Tests Are Common in Children with Chronic Spontaneous Urticaria and Linked to High Disease Activity. Int Arch Allergy Immunol. 2016;171(2):81-88. Epub 2016 Nov 16. PubMed PMID:27846634; doi:  10.1159/000451084. Highlights from this Publication “Our study provides, for the
Continue Reading

Basophil Activation Test Identifies the Patients with Chronic Spontaneous Urticaria Suffering the Most Active Disease

Flow CAST® Assay: Curto-Barredo L, Yelamos et al. Basophil Activation Test identifies the patients with Chronic Spontaneous Urticaria suffering the most active disease. Immun Inflamm Dis. 2016 Oct 4;4(4):441-445. eCollection 2016 Dec. PubMed PMID: 27980778; doi:  10.1002/iid3.125. Highlights from this Publication “BAT was performed, measuring expression of the CD63 surface marker on basophils from whole blood by
Continue Reading

Assessment of Sensitization to Grape and Wine Allergens as Possible Causes of Adverse Reactions to Wine: A Pilot Study

Flow CAST® Assay: Jaeckels N, Bellinghausen I, Fronk P, Heydenreich B, Saloga J, Decker H. Assessment of sensitization to grape and wine allergens as possible causes of adverse reactions to wine: a pilot study. Clin Transl Allergy. 2015 Jun 22;5:21.PMID: 26101585  DOI: 10.1186/s13601-015-0065-8 Highlights from this Publication This article show the unique potential of BAT testing for studying specific allergies when
Continue Reading

Anaphylaxis to Galacto-Oligosaccharides–An Evaluation in an Atopic Population in Singapore

Flow CAST® Assay: Soh JY, Huang CH, Chiang WC, Llanora GV, Lee AJ, Loh W, Chin YL, Tay VY, Chan YH, Dianne D, Lee BW. Anaphylaxis to galacto-oligosaccharides--an evaluation in an atopic population in Singapore.. Allergy. 2015 Aug;70(8):1020-3. Epub 2015 May 22.PMID: 25951913 DOI: 10.1111/all.12645 Highlights from this Publication  "By extrapolating the BAT and oral challenge results, the prevalence
Continue Reading

Systematic Characterization of Basophil Anergy

Flow CAST® Assay: Puan KJ, Andiappan AK, Lee B, Kumar D, Lai TS, Yeo G, Bercin D, Starke M, Haase D, Lum J, Chew FT, Connolly J, Wong SC, Zolezzi F, Poidinger M, Wang DY, Rotzschke O. Systematic characterization of basophil anergy. Allergy 2016; PMID: 27271846 DOI: 10.1111/all.12952 Highlights from this Publication “We present a novel data-driven flow cytometric
Continue Reading